Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease

Restorative Neurology and Neuroscience

Volumn 31, Issue 1, 2013, Pages 41-52

  Zhang, Lan ^a   Yu, Shun ^a   Zhang, Ruyi ^a   Xing, Ying ^a   Li, Yaohua ^a   Li, Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

synuclein; 2,3,5,4 tetrahydroxy stilbene 2 O D glucoside; Alzheimer's disease; APPV717I transgenic mice; hippocampus; Polygonum multiflorum

Indexed keywords

2,3,5,4' TETRAHYDROXY STILBENE 2 O BETA D GLUCOSIDE; ALPHA SYNUCLEIN; COMPLEMENTARY DNA; GLUCOSIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; DATA INTERPRETATION, STATISTICAL; DNA, COMPLEMENTARY; GLUCOSIDES; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROARRAY ANALYSIS; NOOTROPIC AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES;

EID: 84873651372     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-120260     Document Type: Article

References (44)

1. Bai, H.B.,Wang, J.F.&Long, J. (2004). Study on optimizing extraction process of root of Polygonum multiflorum. China J Chin Mat Med, 29(3), 219-221.
2. Bennett, M.C. (2005). The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther, 105(3), 311-331.
3. Chang, Y., Qin, C., Yin, H.X., Zhu, H. & Cai, Y.Y. (2000). Establishment of the transgenic model of Alzheimer disease. Acta Anatomica Sinica, 31(2), 144-147.
4. Citron, M., Diehl,T.S., Gordon, G., Biere, A.L., Seubert, P.&Selkoe, D.J. (1996). Evidence that the 42-and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc Natl Acad Sci USA, 93(23), 13170-13175.
5. Deramecourt, V., Bombois, S., Maurage, C.A., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F. & Delacourte, A. (2006). Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol, 65(3), 278-288.
6. Dewachter, I., van Dorpe, J., Spittaels, K.,Tesseur, I.,Van Den Haute, C., Moechars, D. & Van, L.F. (2000). Modeling Alzheimer's disease in transgenic mice: Effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice. Exp Gerontol, 35(6-7), 831-841.
7. Dewachter, I., Filipkowski, R.K., Priller, C., Rise, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., Godaux, E., Kaczmarek, L., Herms, J. & Van, L.F. (2009). Deregulation of NMDA-receptor function and downstream signaling in APP[V717I] transgenic mice. Neurobiol Aging, 30(2), 241-256.
8. Gentile, A., Amadoro, G., Corsetti, V., Ciotti, M.T., Serafino, A. & Calissano, P. (2008). Spontaneous aggregation and altered intracellular distribution of endogenous alpha-synuclein during neuronal apoptosis. J Alzheimers Dis, 13(2), 151-160.
9. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N. & James, L. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 349(6311), 704-706.
10. Jakes, R., Spillantini, M.G. & Goedert, M. (1994). Identification of two distinct synucleins from human brain. FEBS Lett, 345(1), 27-32.
11. Jellinger, K.A. (2004). Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm, 111(10-11), 1219-1235.
12. Kurata, T., Kawarabayashi, T., Murakami, T., Miyazaki, K., Morimoto, N., Ohta, Y., Takehisa, Y., Nagai, M., Ikeda, M., Matsubara, E., Westaway, D., Hyslop, P.S., Harigaya, Y., Kamiya, T., Shoji, M. & Abe, K. (2007). Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. J Neurosci Res, 85(10), 2246-2252.
13. Lewis, K.A., Su, Y., Jou, O., Ritchie, C., Foong, C., Hynan, L.S., White, C.L. 3rd, Thomas, P.J. & Hatanpaa, K.J. (2010). Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol, 177(6), 3037-3050.
14. Liu, C., Zhang, Q. & Zhou, Q. (1991). Assay of stilbene glucoside in Polygonum multiflorum Thunb and its processed products. China J Chin Mat Med, 16(8), 469-472, 511.
15. Liu, Q.L., Xiao, J.H., Ma, R., Ban, Y. & Wang, J.L. (2007). Effect of 2,3,5,4-tetrahydroxystilbene-2-O-beta-d-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells. J Asian Nat Prod Res, 9(8), 689-697.
16. Lopez, O.L., Wisniewski, S., Hamilton, R.L., Becker, J.T., Kaufer, D.I. & DeKosky, S.T. (2000). Predictors of progression in patients with AD and Lewy bodies. Neurology, 54(9), 1774-1779.
17. Mandal, P.K., Pettegrew, J.W., Masliah, E., Hamilton, R.L. & Mandal, R. (2006). Interaction between Abeta Peptide and Alpha Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer's and Parkinson's in Dementia with Lewy Body Disease. Neurochem Res, 31(9), 1153-1162.
18. Maroteaux, L., Campanelli, J.T. & Scheller, R.H. (1988). Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci, 8(8), 2804-2815.
19. Maroteaux, L. & Scheller, R.H. (1991). The rat brain synucleins; family of proteins transiently associated with neuronal membrane. Brain Res Mol Brain Res 11(3-4), 335-343.
20. Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M. & Mucke, L. (2001). beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A, 98(21), 12245-12250.
21. Mikolaenko, I., Pletnikova, O., Kawas, C.H., O'Brien, R., Resnick, S.M., Crain, B. & Troncoso, J.C. (2005). Alpha-synuclein lesions in normal aging. Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol, 64(2), 156-162.
22. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C.V., Checler, F., Godaux, E., Cordell, B. & Van, L.F. (1999). Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem, 274(10), 6483-6492.
23. Pletnikova, O., West, N., Lee, M.K., Rudow, G.L., Skolasky, R.L., Dawson, T.M., Marsh, L. & Troncoso, J.C. (2005). Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging, 26(8), 1183-1192.
24. Rat, D., Schmitt, U., Tippmann, F., Dewachter, I., Theunis, C., Wieczerzak, E., Postina, R. & van, L.F. (2011). Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J, 25(9), 3208-3218.
25. Ryu, G., Ju, J.H., Park, Y.J., Ryu, S.Y., Choi, B.W. & Lee, B.H. (2002). The radical scavenging effects of stilbene glucosides from Polygonum multiflorum. Arch Pharm Res, 25(5), 636-639.
26. Selkoe, D.J. (1996). Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem, 271(31), 18295-18298.
27. Sturchler-Pierrat, C., Abramowski, D., Duke, M.,Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P.A., Waridel, C., Calhoun, M.E., Jucker, M., Probst, A., Staufenbiel, M. & Sommer, B. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A, 94(24), 13287-13292.
28. Tanghe, A., Termont, A., Merchiers, P., Schilling, S., Demuth, H.U., Scrocchi, L., Van, L.F., Griffioen, G. & Van, D.T. (2010). Pathological, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model. Int J Alzheimers Dis, doi: 10.4061/2010-417314.
29. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A.,Kondo, J., Ihara,Y.&Saitoh,T. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA, 90(23), 11282-11286.
30. Vanhoutte, G., Dewachter, I., Borghgraef, P., Van Leuven, F. & Van der Linden, A. (2005). Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.Magn Reson Med, 53(3), 607-613.
31. Vila, M., Vukosavic, S., Jackson-Lewis, V., Neystat, M., Jakowec, M. & Przedborski, S. (2000). Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem, 74(2), 721-729.
32. Vivacqua, G., Yin, J.J., Casini, A., Li, X., Lim, Y.H., D'Este, L., Chan, P., Renda, T.G. & Yu, S. (2009). Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies. Neuroscience, 158(4), 1478-1487.
33. Wakisaka, Y., Furuta, A., Tanizaki, Y., Kiyoharam, Y., Iida, M. & Iwaki, T. (2003). Age-associated prevalence and risk factors of Lewy body pathology in a general population: The Hisayama study. Acta Neuropathol, 106(4), 374-382.
34. Wang, H., Wang, M., Wang, B., Li, M., Chen, H., Yu, X., Zhao, Y., Feng, W. & Chai, Z. (2012). The distribution profile and oxidation states of biometals in APP transgenic mouse brain: Dyshomeostasis with age and as a function of the development of Alzheimer's disease. Metallomics, 4(3), 289-296.
35. Wang, R., Tang, Y., Feng, B., Zhang, L. & Li, L. (2007). Changes in hippocampal synapses and learning-memory ability in ageincreasing rats and effects of Tetrahydroxy-stilbene glucoside in aged rats. Neuroscience, 149(4), 739-746.
36. Wang, T., Gu, J.,Wu, P.F.,Wang, F., Xiong, Z.,Yang,Y.J.,Wu,W.N., Dong, L.D.&Chen, J.G. (2009). Protection by tetrahydroxystilbene glucoside against cerebral ischemia: Involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation. Free Radic Biol Med, 47(3), 229-240.
37. Wang,W., Li, L. & AI, H.X. (2006). Distribution and metabolism of Tetrahydroxystilbene Glucoside from Polygonum Multiflorum in rabbits. Chin Med Res Prac, 2(4), 108-110.
38. Wei, H., Cai, Y., Chu, J., Li, C. & Li, L. (2008). Temporal gene expression profile in hippocampus of mice treated with D-galactose. Cell Mol Neurobiol, 28(5), 781-794.
39. Xing,Y., Zhang, L.&Li, L. (2006). Effects of tetrahydroxy- stilbeneglucoside on learning and memory abilities and cerebral betaamyloid expression in APP transgenic mice. Chin New Drugs J, 15(7), 510-513.
40. Younkin, S.G. (1995). Evidence that A beta 42 is the real culprit in Alzheimer's disease. Ann Neurol, 37(3), 287-288.
41. Yu, S., Li, X., Liu, G., Han, J., Zhang, C., Li, Y., Xu, S., Liu, C., Gao, Y., Yang, H., U'eda, K. & Chan, P. (2007). Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience, 145(2), 539-555.
42. Zhang, J., Wu, X., Qin, C., Qi, J., Ma, S., Zhang, H., Kong, Q., Chen, D., Ba, D.&He,W. (2003). A novel recombinant adenoassociated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease. Neurobiol Dis, 14(3), 365-379.
43. Zhang, L., Xing, Y., Ye, C.F., Ai, Wei, H.X. & Li, H.F., L. (2006). Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside. Behav Brain Res, 173(2), 246-254.
44. Zhang, W., Wang, C.H., Li, F. & Zhu, W.Z. (2008). 2,3,4-,5-Tetrahydroxystilbene-2-O-beta-D-glucoside suppresses matrix metalloproteinase expression and inflammation in atherosclerotic rats. Clin Exp Pharmacol Physiol, 35(3), 310-316.